Immunotherapy for Hepatocellular Carcinoma: Is Latin America Ready for Primetime?
Guillermo D. Mazzolini, Alexis Iracheta, Mariana Malvicini, Juan Bayo – 22 September 2020
Particularities of Autoimmune Hepatitis in Latin America
Debora Terrabuio, Gilda Porta, Eduardo Cançado – 22 September 2020
Impact of Herbal and Dietary Supplements Causing Drug‐Induced Liver Injury in Latin America
Vinicius Nunes, Nahum Mendez‐Sanchez – 22 September 2020
Hepatitis E Virus Infection: Is It Really a Problem in Latin America?
María Belén Pisano, Santiago Mirazo, Viviana E. Re – 22 September 2020
Liver Injury in Liver Transplant Recipients With Coronavirus Disease 2019 (COVID‐19): U.S. Multicenter Experience
Atoosa Rabiee, Brett Sadowski, Nia Adeniji, Ponni V. Perumalswami, Veronica Nguyen, Akshata Moghe, Nyan L. Latt, Sonal Kumar, Costica Aloman, Andreea M. Catana, Patricia P. Bloom, Kenneth D. Chavin, Rotonya M. Carr, Winston Dunn, Vincent L. Chen, Elizabeth S. Aby, Jose D. Debes, Renumathy Dhanasekaran, the COLD Consortium – 22 September 2020
Working Toward Elimination of Hepatitis C: The Kentucky Hepatitis Academic Mentorship Program
Barbra Cave, Kathy Sanders, Susan Moser, Robert Brawley, Tina McCormick, Claudia Espinosa – 22 September 2020
Are We Really Taking Care of Alcohol‐Related Liver Disease in Latin America?
Juan Pablo Arab, Ramon Bataller, Juan Pablo Roblero – 22 September 2020
The Importance of Knowing the Local Epidemiology When a Patient With Cirrhosis Acquires a Bacterial Infection
Sebastián Marciano, Marcelo Valverde, Melisa Dirchwolf, María Nelly Gutierrez‐Acevedo, Adrián Gadano – 22 September 2020
Hepatitis B Virus and Delta Infection: Special Considerations in the Indigenous and Isolated Riverside Populations in the Amazon Region
César Cabezas, Wornei Braga – 22 September 2020
Consequences of Extended Spectrum Beta‐Lactamase–Producing Enterobacteriaceae and Methicillin‐Resistant Staphylococcus aureus Carriage in Awaiting Liver Transplant Patients
Bianca Magro, Alessandra Mazzola, Mona Munteanu, Claire Goumard, Valerie Martinez, Denis Bernard, Olivier Scatton, Salvatore Battaglia, Ciro Celsa, Calogero Cammà, Filomena Conti – 21 September 2020 – Infections in patients with cirrhosis are associated with liver‐related complications (LRCs), especially in patients awaiting liver transplantation (LT). The aim of this study was to evaluate the impact of methicillin‐resistant Staphylococcus aureus (MRSA) and extended spectrum beta‐lactamase colonization on infections and LRCs for patients on the wait list and on infections after LT.